glutathione reductase inhibitor inhibition of human by s nitrosoglutathione Therapeutic potential S-nitrosoglutathione in B cell-driven experimental autoimmune encephalomyelitis Glutathione system enhancement for cardiac – Frontiers | Glutathione-the “master” antioxidant

GSH modulates monocyte recruitment and macrophage polarization

this underscores the importance of receiving IV therapy in a licensed clinical setting with appropriate monitoring Glutathione should be used with clinical oversight in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency What is not a safety concern at standard therapeutic doses: Organ toxicity at standard wellness dosing is not documented in the clinical literature Interactions with common medications are not widely reported at standard doses, though patients on immunosuppressants or chemotherapy should disclose this to their provider Glutathione in Context: What It Is Not Glutathione is not a cure or treatment for any specific disease, and IV glutathione in a wellness setting is not equivalent to pharmaceutical intervention for diagnosed conditions

Confusing topical and injectable doses

Most protocols suggest 812 weekly sessions initially, then monthly maintenance